This Drug Approved for One Condition Treats 12 Others Off-Label
Gabapentin — sold under the brand name Neurontin — was approved by the FDA to treat partial onset seizures in people with epilepsy.
Category Diet
New Drug for Alopecia Universalis — Total Hair Loss Finally Has a Treatment
For the millions of people living with alopecia universalis — the complete loss of all body hair — the past few years have delivered something that was...
New Study Says This Popular Supplement May Interact With 200 Drugs
A widely cited body of research has identified St. John's wort — one of the most commonly purchased herbal supplements in the United States and Europe —...
New Treatment for Chronic Rhinosinusitis Doesn’t Require Surgery
For the millions of people living with chronic rhinosinusitis, a condition marked by persistent inflammation of the sinuses lasting twelve weeks or...
The Drug That Allows Transplant Patients to Eat Grapefruit Again
The drug is Envarsus XR, an extended-release formulation of tacrolimus that uses a delivery technology called MeltDose to release the medication further...
The MS Drug Requiring a Brain Scan Before Every Dose
The multiple sclerosis drug that requires a brain scan before every single infusion is natalizumab, sold under the brand name Tysabri.
New Drug for Alopecia Areata Regrows Hair in Majority of Patients
A class of drugs known as JAK inhibitors has emerged as the first FDA-approved treatment specifically for severe alopecia areata, and clinical trial data...
The Drug That Treats Both Type 1 and Type 2 Diabetes Differently
The drug that treats both Type 1 and Type 2 diabetes — but through fundamentally different mechanisms — is sotagliflozin, marketed as Inpefa.
This Immunotherapy for Peanut Allergy Changes Food Allergy Treatment Forever
For the roughly 6.1 million Americans living with peanut allergy, the fear of accidental exposure has long been managed with one blunt tool: avoidance.
The Eye Injection That Treats Wet Macular Degeneration Monthly
The eye injection that treats wet macular degeneration on a monthly basis is ranibizumab, sold under the brand name Lucentis.